Effects of S-1 and Capecitabine in Combination With Oxaliplatin on the Coronary Artery Blood Flow in Patients Metastatic Gastrointestinal Tract Adenocarcinoma: a Randomized Phase II Study
Phase of Trial: Phase II
Latest Information Update: 19 Jul 2019
Price : $35 *
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Capecitabine; Oxaliplatin
- Indications Adenocarcinoma; Gastrointestinal cancer
- Focus Adverse reactions
- 19 Jul 2019 This trial has been completed in Denmark, according to European Clinical Trials Database.
- 27 Aug 2018 Status changed from recruiting to discontinued.
- 09 Mar 2014 New trial record